Microporation techniques for enhanced delivery of therapeutic agents

Recent Patents on Drug Delivery and Formulation

Volumn 4, Issue 1, 2010, Pages 1-17

  Singh, Thakur R R ^a   Garland, Martin J ^a   Cassidy, Corona M ^a   Migalska, Katarzyna ^a   Demir, Yusuf K ^a   Abdelghany, Sharif ^a   Ryan, Elizabeth ^a   Woolfson, David ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Electroportaion; Jet injection; Microneedles; Microporation; Minimally invasive monitoring; Radiofrequency; Sonophoresis; Thermal ablation; Transdermal drug delivery

Indexed keywords

DNA; EXENDIN 4; HUMAN GROWTH HORMONE; IDFLU; INFLUENZA VACCINE; INTANZA; PARATHYROID HORMONE[1-34]; PEPTIDE DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DRUG;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ELECTROPORATION; HUMAN; JET INJECTION; JET INJECTOR; LASER; MICROINJECTOR; PATENT; POROSITY; PRIORITY JOURNAL; RADIOFREQUENCY; RISK ASSESSMENT; SKIN PENETRATION; TRANSDERMAL PATCH; TRANSMEMBRANE DRUG DELIVERY; ULTRASOUND; ANIMAL; ATMOSPHERIC PRESSURE; HEAT; INTRADERMAL DRUG ADMINISTRATION; PHYSIOLOGY; RADIOFREQUENCY RADIATION; REVIEW; SAFETY; SKIN ABSORPTION; SOLUTION AND SOLUBILITY;

ADMINISTRATION, CUTANEOUS; AIR PRESSURE; ANIMALS; DRUG DELIVERY SYSTEMS; HOT TEMPERATURE; HUMANS; LASERS; PHARMACEUTICAL PREPARATIONS; PHARMACEUTICAL SOLUTIONS; RADIO WAVES; SAFETY; SKIN ABSORPTION; ULTRASONICS;

EID: 77449143848     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221110789957174     Document Type: Article

References (162)

1. Barry BW. Novel mechanisms and devices to enable successful transdermal delivery. Eur J Pharm Sci 2001; 14: 101-114.
2. White SH, Mirejovsky D, King GI. Structure of lamellar lipid domains and corneocytes envelops of murine stratum corneum. An X-ray diffraction study. Biochemistry 1988; 27: 3725-3732.
3. Bouwstra JA, Ooris GS, Van der spek JA, Lavrijsen S, Bras W. The lipid and protein structure of mouse stratum corneum: A wide and small angle diffraction study. Biochim Biophys Acta 1994; 1212:183-192.
4. Wang B, Teruna S, Soltero R. Physiological, biochemical, and chemical barriers to oral drug delivery. Drug delivery principles and applications. New Jersey: John Wiley & Sons Inc 2004; 15-26.
5. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008; 26(11): 1261-1268.
6. Anubhav A, Prausnitz MR, Samir M. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008; 364(2): 227-236.
7. Kalia YN, Naik A, James G, Richard HG. Iontophoretic drug delivery. Adv Drug Deliv Rev 2004; 56: 619-658.
8. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin-a mechanism to enhance transdermal drug- delivery. Proc Natl Acad Sci USA 1993; 90 (22): 10504-10508.
9. Birchall J, Coulman S, Anstey A, et al. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm 2006; 312: 15-23.
10. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995; 269 (5225): 850-853.
11. Moatti-Sirat D, Capron F, Poitout V, et al. Towards continuous glucose monitoring: in vivo Evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue. Diabetologia 1992; 35: 224-230.
12. Schmidtke DW, Freeland AC, Heller A, Roger TB. Measurement and modeling of the transient difference between blood and subcutaneous glucuose concentrations in the rat after injection of insulin. Proc Natl Acad Sci USA 1998; 95: 294-299.
13. Tamada JA, Bohannon NJ, Potts RO. Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat Med 1995; 1: 1198-1201.
14. Pfeiffer EF, Meyerhoff C, Bischof F, Keck FS, Kerner W. Online continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensors with microdialysis. Eur J Clin Invest 1995; 25: 601-607.
15. Fischer U, Ertle R, Abel P, et al. Assessment of subcutaneous glucose concentration: Validation of the wick technique as a reference for implanted electrochemical sensors in normal diabetic dogs. Diabetologia 1987; 30: 940-945.
16. Bantle JP, Thomas W. Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid. J Lab Clin Med 1997; 130: 436-441.
17. Baxter J, Mitragotri S. Jet-induced skin puncture and its impact on needle-free jet injections: Experimental studies and a predictive model. J Control Release 2005; 106: 361-373.
18. Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 2006; 5: 543-548.
19. Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm 2008; 364: 227-236.
20. Weston, T.E.: US5891086A (1995).
21. Green, T.: US20080119783A1 (2008).
22. Oconnor C, Zogenix website, http://www.zogenix.com [Accessed 19/02/2009].
23. Slate, J.B., Burk, M.W., Gorton, L.A.: US5911703A (1999).
24. Castellano, T.P., Schumacher, R.: US20006063053A (2000).
25. National Medical Products inc, J-tip Needle free injector website, http://www.jtip.com [Accessed 19/02/2009].
26. Broullette, M., Dufresne, S.: US20050154368A1 (2005).
27. Laundau, S., Marshall, J.R., Niguel, L.: US20056935384B2 (2005).
28. Bioject Inc., Bioject Website, http://www.bioject.com [Accessed 19/02/2009].
29. Alexandre, P., Brouqueries, B., Desailly, D.: US20067455655B2 (2006).
30. TM Website, http://www.crossject.com [Accessed 19/02/2009].
31. Gilbert, J.S., Menlo, P.: EP1752177A1 (2007).
32. Bellhouse, B.J., Sarphie, D.F., Greenford, J.C.: US20070299390A1 (2007).
33. Schmeltz, A., Dunne, M., Pfizer's Infectious disease commitment and portfolio 2007. http://www.pfizer.com/files/investors/ presentations/icaac_2007_presentation_071807.pdf [Accessed 19/02/2009].
34. Arora, A., Mitragotri, S., Ahmet, T.: US20090030367 (2009).
35. Hingson RA, Davis HS, Rosen M. The historical development of jet injection and envisioned uses in mass immunization and mass therapy based upon 2 decade's experience. Mil Med 1963; 128: 516-524.
36. Birchall J, Coulman S, Anstey A, et al. Cutaneous gene expression of plazmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm 2006; 312: 15-23.
37. Levin G, Gershonowitz A, Sacks H, et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 2005; 22(4): 550-555.
38. Sintov AC, Krymberk I, Daniel D, Hannan T, Sohn Z, Levin G. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release 2003; 89: 311-320.
39. Avrahami, Z.: US20006148232 (2000).
40. Avrahami, Z.: US20046711435 (2004).
41. Avrahami, Z., Yossi, G., Ze'ev, S.: US20036597946 (2003).
42. Avrahami, Z., Ze'ev, S.: US20036611706 (2003).
43. Avrahami, Z., Ze'ev, S.: US20046708060 (2004).
44. TransPharma Medical™ Ltd. http://www.transpharma- medical.com/ [Accessed on 27/2/2009].
45. Levin, G., Meir, S., Dorit, D.: US20050287217 (2005).
46. Levin, G., Dorit, D.: US20050260252 (2005).
47. Levin, G., Hagit, S., Sergey, R.: US20070270732 (2007).
48. Levin, G., Amikan, G., Hana, G.: US20070009542 (2007).
49. Levin, G.: US20070292445 (2007).
50. Levin, G., Amikan, G., Meir, S., Amir, S.: US20070260170 (2007).
51. Konno, Y., Kawata, H., Aruga, M., Sonobe, T., Mitomi, M.: US4685911 (1987).
52. Kuratomi, Y., Miyauchi, K.: US4747841 (1988).
53. Stewart, R.F.: US4830855 (1989).
54. Ajay KB. Therapeutic peptides and proteins: Formulation, processing, and delivery systems, second edition. Florida CRC: Tylor Francis 2006; 264-265.
55. Wilson, D.R., Fallon, R.A.: WO93007842 (1993).
56. Eppstein, J.A.: WO98029134 (1998).
57. Eppstein, J., Hatch, M., Yang, D.: US5885211 (1999).
58. Eppstein, J., Hatch, M.R., Papp, J.: WO00074767 (2000).
59. Eppstein, J.: US20016173202 (2001).
60. Eppstein, J., Hatch, M., Papp, J.: US20046692456 (2004).
61. Eppsteiin, J., McRae, S.: US20046685699 (2004).
62. Praunsnitz, M.R., Allen, M.G., Park, J., Yoon, Y., Park, J.: WO2006004595 (2006).
63. Chelak, T. M.: WO2007127339 (2007).
64. Altea Therapeutics, http://www.alteatherapeutics.com/ [Accessed on 09/04/2009].
65. TechConnect, http://www.techconnect.org/news/press/item.html? id=216 [Accessed 09/04/2009].
66. Weimann, J.: WO2004060447 (2004).
67. Eppstein, J.: US20036527716 (2003).
68. Kollias, N., Sun, Y., Coston, A.F.: US20087404815 (2008).
69. Nelson JS, McCullough JL, Glenn TC, Wright WH, Liaw LH, Jacques SL. Midinfrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. J Invest Dermatol 1991; 97: 874-879.
70. Bragagna, T., Reinhard, B., Daniel, G., Bernhard, N., Christof, B.: US20080208104A1 (2008).
71. Bohler, C., Bragagna, T., Reinhard, B., Werner, B., Herbert, Z.: US20080255034A1 (2008)
72. Bragagna, T., Reinhard, B., Daniel, G., Bernhard, N.: EP051704 (2005).
73. Bragagna, T., Reinhard, B., Daniel, G., Bernhard, N.: WO2006111200 (2006).
74. Bragagna, T., Reinhard, B., Daniel, G., Bernhard, N.: WO2006111199 (2006).
75. Bragagna, T., Reinhard, B., Daniel, G., Bernhard, N., Christof, B.: WO2006111429 (2006).
76. Pantec Biosolution, http://www.pantec-biosolutions.com/index. php?src=news&refno=21 [Accessed online on 25/04/2009].
77. Epiture easytouch, http://www.epitureeasytouch.com/ [Accessed online on 25/04/2009].
78. Mitragotri, S.S., Blankschtein, D., Langer, R.S.: US20006018678A (2000).
79. Ng K, Lui Y. Therapeutic ultrasound: Its application in drug delivery. Med Res Rev 2002; 22(2): 204-223.
80. Harvey CJ, Pilcher JM, Eckersley RJ, Blomley MJK, Cosgrove DO. Advances in ultrasound. Clin Radiol 2002; 57: 157-177.
81. Machet L, Boucaud A. Phonophoresis: Efficiency, mechanisms and skin tolerance. Int J Pharm 2002; 243(1-2): 1-15.
82. Lavon I, Kost J. Ultrasound and transdermal drug delivery. Drug Discov Today 2004; 8; 9(15): 670-676.
83. Tachibana K, Tachibana S. Application of ultrasound energy as a new drug delivery system. Jpn J Appl Phys Part 1-Regular Papers Short Notes Rev Pap 1999; 38(5B): 3014-3019.
84. Joshi A, Raje J. Sonicated transdermal drug transport. J Control Release 2002; 9/18; 83(1): 13-22.
85. Gustavo M, Yogeshvar NK, Richard HG. Ultrasound-enhanced transdermal transport. J Pharm Sci 2003; 92 (6): 1125-1137.
86. Ogden, J.E.: US5656016 (1997).
87. Lipkovker, L.M.: US5617851 (1997).
88. Lipkovker, L.M.: US5421816 (1995).
89. Mitragotri, S.S., Blankschtein, D., Langer, R.S.: US6002961 (1999).
90. Mitragotri, S.S., Blankschtein, D., Langer, R.S.: US5814599 (1998).
91. Redding, B.K.: US20087440798B2 (2008).
92. Hille, T., Hehn, B.: US20056868286B1 (2005).
93. Nunomura, M., Oba, T., Matsumura, Y., Nonaka, G., Tanaka, H.: US20067001355B2 (2006).
94. Rowe, S., Kost, J., Mitragotri, S.S., Pishko, M., Davis, M.: US20016234990B1 (2001).
95. Johnston, M.E., Mitragotri, S.S., Blankschtein, D., Langer R.S., Pishko, M., Kost, J.: US5947921 (1999).
96. Kost, J., Pliquett, U., Mitragotri, S.S., Langer, R.S., Weaver, J.C.: US20006041253A (2000).
97. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995; 269 (5225): 850-853.
98. Mitragotri SS, Blankschtein D, Langer RS. Transdermal drug delivery using low-frequency sonophoresis. Pharm Res 1996; 13: 411-420.
99. Banga AK, Prausnitz MR. Assessing the potential of skin electroporation for the delivery of protein- and gene-based drugs. Focus 1998; 16: 408-412.
100. Wong TW, Shu-Fen K, Sek-Wen H. Enhancing transdermal drug delivery with electroporation. Recent Pat Drug Deliv Formul 2008; 2(1): 51-57.
101. Mathiesen, I., Torunn, T., Knut, A.S.R., Bjorn, D.A.: US20080234655 A1 (2008).
102. Chang, K., Goldberg, D.I., Etheredge, R.W., Barsness, M.S.: US20080312579A1 (2008).
103. Jaroszeski, M., Lopez-diaz, G.A., Connolly, R.J., Hoff, A.M.: US20090004717A1 (2009).
104. Genetronics, http://www.genetronics.com/technology/dnadelivery systems.htm [Accessed online on 04/05/2009].
105. Gerstel, M.S., Place V.A.: US3964482 (1976).
106. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1998; 87(8): 922-925.
107. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004; 56 (5): 581-587.
108. Ryan FD, Anthony M, Paul AM, David AW. Microstructured devices for transdermal drug delivery and minimally-invasive patient monitoring. Recent Pat Drug Deliv Formul 2007; 1: 195-200
109. Mischler, R., Gerhard, W.: US20070191696 (2007).
110. Prausnitz, M.R., Allen, M.G., Gujral, I.J.: US20087344499 (2008).
111. Angel, A.B., Hunter, I.W.: US20087364568 (2008a).
112. Angel, A.B., Hunter, I.W.: US20087429258 (2008b).
113. Hoarau, C., Li, L., Keith, B., Shannon, C.: US20080221408A1 (2008).
114. Gonnelli, R.R.: US20090062752A1 (2009).
115. Delmore, M.D., Patrick, F.R., Douglas, H.A., Cristina, U.T., Richard, F.H.: US20050143713 (2005)
116. Gonnelli, R.R.: US20050137536 (2005).
117. Eriksson, E., Christian, B., Robert, W. A., Tom, J., Anthony, D., David, P., Denis, L., John, N., Patrick, G.: US20087422574 (2008).
118. Cantor, A.S.: US20080009811 (2008).
119. Kirby, A.J.: US20080140049 (2008).
120. Lavi, G.: US20080015516 (2008).
121. Singh, P., Robert, W.W., Joseph, T., Danir, B., Lee, B. D., Andy, K., Richard, K.S., Guohua, C.: US20080269685 (2008).
122. Stinchcomb, A.L., Stan, B.L., Raghotham, P.R.: US20080008745 (2008).
123. Morrison, J.C., Moore, C.G.: US5364374 (1994).
124. Reed ML, Lye WK. Microsystems for drug and gene delivery. Proc IEEE 2004; 92(1): 56-75.
125. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004; 56(5): 581-587.
126. Park J-H, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery. J Control Release 2005; 104(1): 51-66.
127. Stupar PA, Pisano AP. Silicon, parylene and silicon/parylene microneedles for strength and toughness. IEEE Int Conf on Solid State Sensors and Actuators, Transducers. Munich, Germany 2001.
128. Aoyagi S, Izumi H, Aoki T, Fukuda M. Development of a micro lancet needle made of biodegradable polymer for low-Invasive medical treatment. Proc Transducers 2005: 1195-1198.
129. Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008; 29(13): 2113-2124.
130. Clarke, G.M., Delmore, M.D., Domroese, M.K., Ferber, R.H., Jacobs, J.D., Jamieson, K.C., Franklyn, F. L.: US20050261631 (2005).
131. Jung, H., Lee, K.: US20080108959 (2008).
132. Ogawa, S.: US20080221532 (2008).
133. Kasper, R.L., Speaker, T.: US20090043279A1 (2009).
134. Verbaan FJ, Bal SM, Van den Berg DJ, et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release 2008; 128: 80-88.
135. Yuzhakov, V.V.: US20080125743 (2008).
136. Laermer, F., Michael, S., Dick, S., Christian, M.: US20080167601 (2008).
137. Lee, J., Hong, S.: US2008016735A1 (2008a).
138. Lee, J., Hong, S.: US20080161747A1 (2008b).
139. MTS Roller. http://www.microneedle.com/main/index.html [Accessed online on 05/05/2009].
140. Trautman, J.C., Worsham, R.W., Bayramov, D.F., Bowers, D.F., Klemm, S.R., Singh, P.: US2008000824 (2008).
141. Corium International, http://www.coriumgroup.com/downloads/ seriescpressrelease.pdf [Accessed online on 05/05/2009].
142. Paul, G.A.: US20026494865 B1 (2002).
143. BectonDrive http://www.bd.com/contentmanager/b_article.asp? Item_ID=23817&ContentType_ID=1&BusinessCode=20001&d=B D+Worldwide&s=&dTitle=&dc=&dcTitle [Accessed online on 05/05/2009].
144. Laurent P, Stephane B, Paul A, et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 2007; 25; 8833-8842.
145. Laurent A, Frédéric M, David B, et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 2007; 25 (34):6423-6430.
146. Cormier, M.J.N., Young, W.A., Johson, J.A., Daddona, P.E., Ameri, M.: WO2004002566 (2004).
147. Cormier, M.J.N., Young, W.A., Nyam, K., Daddona, P.E., Lin W.: US20060200069A1 (2006).
148. Zosano Pharma ™, Inc., http://zosanopharma.com/index.php? option=comcontent&task=view&id=12&Itemid=26 [Accessed online on 05/05/2009].
149. Shilpa K, Allen H, Hord D, Denson, DV. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001; 92: 502-504.
150. Bala S, Caussina J, Pavel S, Bouwstra J. in vivo Assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008; 35:193-202.
151. Haq MI, Smith E, John DN, et al. Clinical administration of microneedles: Skin puncture, pain and sensation. Biomed Microdevices 2009; 11: 35-47.
152. http: ww.wfumb.org [Accessed on 07/07/09].
153. Bommannan D, Okuyama H, Stauffer P, Guy R. Sonophoresis: I. The use of high frequency ultrasound to enhance transdermal drug delivery. Pharm Res 1992; 9: 559-564.
154. Weniger BG. New high-speed jet injectors for mass vaccination: Pros and Cons of disposable-cartridge jet injectors (dcjis) versus multi-use-nozzle jet injectors (MUNJIs), in Global Vaccine Research Forum. WHO Initiative for Vaccine Research: Montreux, Switzerland 2004.
155. Weintraub A, de Leon PM. Potential for cross-contamination from use of a needleless injector. Am J Infect Control 1998; 26: 442-445.
156. Dimache G. A clinical, epidemiological and laboratory study on avoiding the risk of transmitting viral hepatitis during vaccinations with the Dermojet protected by an anticontaminant disposable device. Vaccine 1997; 15: 1010-1013.
157. Galit L, Amikam G, Hagit S, et al. Transdermal delivery of human growth hormone through RF-microchannels. Pharm Res 2005; 22: 550-555.
158. Prausnitz MR, Bose VG, Langer R, Weaver JC. Electroporation of mammalian skin: A mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 1993; 90:10504-10508.
159. Vanbever R, Preat V. in vivo Efficacy and safety of electroporation. Adv Drug Deliv Rev 1999; 35: 77-88.
160. Nanda A, Nanda S, Ghilzai NM, et al. Current development using emerging transdermal technologies in physical enhancement methods. Curr Drug Deliv 2006; 3: 233-242.
161. Eppstein, J.A.: US20040220456A1 (2004).
162. Eppstein J.A.: US20070031495A1 (2007).